To meet the project objectives, leading universities in the field of diabetes technology and AP have teamed up with world leading industry. The consortium comprises expertise in the fields of ICT (FG, INR), algorithms (INR), system integration (INR, FG), preclinical testing (UT) clinical trials in diabetes technology and patient acceptance (AMS, GRZ and PRO), glucagon formulation, glucagon pharmacodynamics testing (PRO, AMS and GRA) and the development of single-port AP systems (GRZ and INR).
The partners shall combine and integrate their expertise, knowledge and technologies necessary for the successful completion of this project. This consortium brings together world leading experts in their field and is well balanced regarding the knowledge and expertise for implementation of the project and the dissemination and use of the results.